This report analyzes the transient character of the anti-receptor antiidiotypic response to antibody against catecholamines. The present results suggest that the synthesis of anti-hormone antibodies subsequent to the immunization with antihormone antibody may play a major role in the regulatory network of idiotypic antiidiotypic interactions.
Materials and Methods
Animal Immunization and Preparation of Antibodies. Antiidiotypic antibodies were raised in rabbits by intradermal injection of anti-alprenolol IgG from allotype-matched rabbits. The isolation and purification of IgG was performed by 33% ammonium sulfate precipitation followed by dialysis and ion exchange chromatography on DEAE-cellulose as previously described (12) . The IgG fraction was concentrated by a further ammonium sulfate precipitation and stored in aliquots at -20°C.
Affinity Chromatography. Anti-alprenolol IgG was coupled to Sepharose 4B by cyanogen bromide (CNBr) ~ activation as described by Mach et al. (18) using 4 g of Sepharose 4B (net weight), 0.5 g CNBr, and 40 mg of antibody dissolved in phosphate-buffered saline (PBS). The resulting gel was suspended in PBS containing azide and stored at 4°C.
The immunoabsorbent gel was packed in a column (0.5 × 6 cm). IgG fractions were passed through the column and the gel was washed with PBS until no significant absorbance (<0.01) was detected. Elution was then performed with 3% acetic acid; the eluted fractions were immediately neutralized with Tris-HCl (1 M, pH 8.2). Effluents and eluates were extensively dialyzed against PBS at 4°C, concentrated by vacuum dialysis, and stored in aliquots at -20°C.
Preparation of Turkey Erythrocyte Membranes.
Turkey blood was mixed with citrate buffer and diluted with 145 mM NaC1. After centrifugation, the plasma and buffy coat were removed, The washed cells were lysed in 5 mM Tris-HC1 (pH 7.4), 2 mM MgCI2 buffer and homogenized. After centrifugation, the supernatant was removed and the upper pink layer of the pellet (erythrocyte ghosts) was collected and suspended in 10 mM Tris-HC1 (pH 7.4), 145 mM. NaCI, 2 mM MgC12 (buffer A). After washing, the resulting ghosts were suspended in buffer A containing glycerol and stored in liquid nitrogen. The procedure has been described in detail elsewhere (19) .
Immunofluorescence Studies. Turkey erythrocytes (10 ~ ceils) were incubated with IgG fractions for 1 h at 30°C. After washing with PBS, cells were reincubated with fluorescein isothiocyanatelabeled goat anti-rabbit IgG for 1 h at 30°C. The cells were observed in a Leitz fluorescence microscope (E. Leitz).
Binding Assays. Binding of (-)-[aH]dihydroalprenolol (-)-[3H]
DHA to each fraction was assayed by means of an ammonium sulfate precipitation assay (Farr assay). Briefly, IgG samples were incubated overnight at 4°C with (-)-[3H]DHA, then precipitated with 50% ammonium sulfate, and finally filtered on glass fiber filters. Antiidiotypic IgG was detected by inhibition of (-)-[3H]DHA to fl-adrenergic receptor from turkey erythrocyte membranes. Turkey erythrocyte membranes were preincubated with dilutions of IgG fractions from each bleeding or with dilutions of corresponding passthrough and eluted fractions from the Ab 1-Sepharose gel for 1 h at 30°C in 75 mM Tris-HC1 buffer, pH 7.4/25 mM MgCI~. Membranes were then tested for their ability to bind (-)-[aH]DHA after 8 min incubation at 30°C and finally filtered on glass-fiber filters (12) .
Results
Preparation and Characterization of Anti-alprenolol Antibodies. Antibodies against alprenolol, a potent catecholamine antagonist, were raised in a rabbit by injection of alprenolol linked to bovine serum albumin (20 (-)-[aH]DHA with an apparent dissociation constant of 1.1 X 10 -7 M and represented ~1.5% of the total IgG fraction, further designated as Abl throughout this report. The Ab 1 binds other catecholamine antagonists such as propranolol and agonists such as isoproterenol (12) . The antibody-containing IgG fraction obtained from pooled bleedings from a single animal was injected into four allotypically matched rabbits: 31, 35, 57, and 58 to induce the synthesis of antiidiotypic antibodies (Ab2).
Transient Character of the Antiidiotypic Response to Abl. Antiidiotypic activity was monitored in the serum of the immunized rabbits by following the capacity to inhibit the binding of catecholamine ligands to the anti-alprenolol antibodies and to the Badrenergic receptors (12) . In our initial study (12) , this activity was detected only in the serum of rabbit 31. It appeared the 6th wk after initial immunization, and disappeared 10 wk later. It could not be detected in the serum of the other three immunized rabbits. The transient character of the antiidiotypic response to antialprenolol antibodies was also described in another study in which only 1 animal out of 11 appeared to respond (14) . We were intrigued by this low responsiveness and decided to investigate the presence of antibodies that might neutralize the antiidiotypic antibodies.
Alprenolol-binding Capacity in Sera of Rabbits Immunized with Anti-alprenolol Antibodies.
When testing the IgG fraction from each bleeding from rabbit 31, it appeared that the decrease of adenylate cyclase stimulating antiidiotypic antibodies was accompanied by an increase of alprenolol-binding activity. We therefore decided to investigate this activity in the serum of the apparently nonresponding rabbits. In the IgG fractions of rabbits 57 and 58 we detected several periods of production of anti-alprenolol antibodies ( Fig. 1 ). To differentiate this Abl-like activity from that due to residual Abl injected during the preceding weeks, we determined the ligand-binding affinity of the "new" antibodies: except for the first peak, in both rabbits it appeared to be higher than that of the immunogen, and decreased progressively from one peak to the next (Fig. 2 ). Because we suspected that the Abl-like response was due in fact to antiidiotypic antibodies against Ab2 molecules themselves raised against the injected Ab 1, we prepared an Ab 1-agarose affinity gel to isolate the various antibody activities.
Isolation and Characterization of Ab2 and Abl-like Antibodies. Ig fractions from each bleeding from rabbits 57 and 58 were absorbed on the Ab 1 agarose column and both the effluent ("pass-through") and the eluate were analyzed for the capacity to bind (-)-[aH]DHA (Ab l-like activity) ( Fig. 1) or to inhibit this binding to the fl-adrenergic receptor or to anti-alprenolol antibodies (Ab2 activity).
Alternate peaks of both types of activities could be observed (Fig. 3 B) in either the effluent or the eluate. Ab2 antibodies, not detected in the serum appeared to be able to inhibit almost all the binding of (-)-[aH]DHA to the receptor in a dose-dependent, saturable manner (Fig. 4) . The small amount of Ab2 activity detected in the effluent (Fig. 3 A) might be due to saturation of the Abl column or to competition with the unretained Ab l-like antibodies.
The presence of antiidiotypic Ab2 antibodies able to interact with the alprenolol binding fl-adrenergic receptor (12) was confirmed by immunofluorescence experiments in which turkey erythrocyte membranes known to possess fl-adrenergic receptors were incubated with the various fractions obtained during affinity chromatography on the Ab 1 agarose gel. When FITC-labeled goat anti-rabbit antibodies were added, only the fractions that inhibited the binding of (-)-[aH]DHA to the fl-adrenergic receptor stained the receptor containing membranes.
As for the direct (-)-[SH]DHA-binding capacity, superimposable results were obtained either with entire IgG serum fractions or with the effluent from the Ablagarose gel (Fig. 1) . The comparison of the Ab2 and Abl-like (or Ab3) time courses revealed that the peaks of these two kinds of activities appeared exactly in ahernance all along the 5-mo-long study, independent of the booster injections (Fig. 3 B) .
Interactions of the Ab2 with Both Abl and Ab3. The cyclical appearance of the Ab2 and Abl-like Ab3 antibodies could be explained by reciprocal expansion of idiotypic and antiidiotypic clones (21) and neutralization of antibody activity by antiantibodies. To verify this hypothesis, the Ab2 fractions were preincubated with increasing concentrations of Abl or Ab3, then incubated with membranes and tested for their ability to inhibit the binding of (-)-[3H]DHA to the fl-adrenergic receptor. Both Ab 1 and Ab3 prevented the interaction of Ab2 with the fl-adrenergic receptor. A typical result is shown in Fig. 5 for bleeding 58-4 .
From this experiment, it appeared that Ab3, for example from bleeding 58-5, which was seen to exhibit a higher affinity for (-)-[~H]DHA than Abl (Fig. 3B ) also demonstrated a higher affinity for Ab2 than did Abl (Fig. 5) . Under the same conditions, the effluent of bleeding 58-4, which was negative in the (-) inhibit Ab2. These results were in agreement with our interpretation that antialprenolol antibodies, appearing in the course of the Ab2 immune response, were antiidiotypic with respect to Ab2. Moreover, the binding affinity of Ab2 for Ab 1 and for Ab3 were well conserved during the course of the immune response (Fig. 5) A time course study of the Ab2 response reveals a cyclic appearance of the antiidiotypic molecules. Their disappearance could be explained by metabolism. However, such a process is usually slow compared with the rapid decrease in Ab2 concentration seen in our study. We favor an active removal mechanism likely to result from the synthesis of a third kind of antibody (Ab3) auto-antiidiotypic against Ab2 (21) . We isolated Ab3 by affinity chromatography on an antigen-containing affinity column and were able to compare its precise binding characteristics with those of the Abl antibodies. Some of the Ab3 molecules thus mimicked the Abl original antibodies by binding the catecholamine ligand. It remained to be shown that the Ab3 molecules were not actually Abl, since both bind the ligands and both inhibit the action of Ab2 in binding to the receptor. However, in each of these experiments, the binding properties of Ab 1 and Ab3 were shown to be different.
The results presented here and those described by others (14) on the fl-adrenergic system, as well as the results of Shechter et al. (22) on the insulin system, clearly indicate that the auto-antiidiotypic response induced by the injection of anti-hormone antibodies may actually intervene in physiological processes, as had been suggested earlier by Sege and Peterson (11) . The synthesis by rabbits ofantiidiotypic antibodies that act as anti-receptor antibodies may constitute a potent trigger for the synthesis ofautologous anti-antiidiotypic antibodies that could neutralize potentially detrimental effects of the hormone like immunological internal images. A recent study by Wasserman et al. (16) has shown that this neutralization event actually reverses the pathological developments of experimental autoimmune myasthenia gravis induced in rabbits immunized with antibodies against an acetylcholine analog.
In the present study of rabbits immunized with anti-alprenolol antibody Ab 1, we have shown a cyclic appearance of antiidiotypic antibodies (Ab2), alternating with the appearance of alprenolol-binding antibodies. Anti-receptor Ab2 response, which is only a fraction of the overall antiidiotypic response to the injection of Abl, has been documented in several hormonal systems (10) (11) (12) (13) (14) (15) (16) (17) , wherein most authors have noticed the transient aspect of this response.
Our results confirm that the rapid and cyclic disappearance of anti-receptor Ab2 antibodies is due to a regulation assumed by antiidiotypic antibodies directed against Ab2. This reciprocal expansion ofantiidiotypic clones is supported byJerne's idiotypic network theory (7) and is in agreement with other recent results (21, 23) . Moreover, we have shown that at least a fraction of these anti-antiidiotypic antibodies are able to bind the original antigen, i.e., alprenolol, and thus may be considered as Ab l-like antibodies. It is interesting to underline the general decrease in the affinity of these antibodies towards the antigen all along the immune response. This result suggests a degeneracy in the idiotypic response, as if the image would fit less and less its model.
The anti-antiidiotypic antibodies are heterogeneous; some may be directed against the idiotype of Ab2 involved in this interaction with the hormone receptor. These are the Ab l-like antibodies. Others may be directed against different idiotypes of the Ab2 molecule and have no alprenolol-binding capacity. One hypothesis could be that these anti-antiidiotypic antibodies are responsible for neutralizing the anti-receptor Ab2 antibodies, thus masking the Ab2 activity in the serum of immunized animals in varying proportions according to the animal. Fractionation of the serum on an Ablcontaining affinity column separates the anti-antiidiotypic antibodies from the retained Ab2 molecules and permits detection of the different binding activities of these complementary Ig. Summary Antiidiotype antibodies were raised against anti-catecholamine ligand antibodies. The antiidiotype response was shown to be cyclical and to correspond to the production of antibodies that could bind to catecholamine fl-adrenergic receptors and stimulate adenylate cyclase. Disappearance of these antibodies from the serum could be correlated with the appearance of a catecholamine ligand-binding activity corresponding to the synthesis of autologous anti-antiidiotype antibodies directed against the induced antiidiotypic molecules. Comparison of the injected versus the induced anti-ligand antibodies reveals striking differences in affinities but similarities in the ability to bind to the antiidiotype antibodies and to the ligand-containing affinity gel. The results support the existence of a functional network of idiotype antiidiotype interactions involving external as well as internal antigens, antibodies, and possibly other types of molecules involved in recognition phenomena, such as hormone receptors.
